TONSL and neoplasm: TONSL variants were observed in 5/14 (36%) patients, all of which belonged to the high HLA-A expression group, as determined by NGS; the presence of a TONSL mutation was significantly associated with high HLA-A expression in tumor cells (Fig. 4a; Supplementary Table S5).